Skip to main content
Company record · Couvin
Belgian companySituation normaleSociété à responsabilité limitée

NAMVET

Enterprise number
0793.810.782
VAT number
BE0793810782
Registered office
Rue de la Platinerie, Peti. 29, 5660 Couvin
Incorporated on
21 November 2022
Members only
Health score
Latest financial year
2025
m87-f model
Size
Not published
Workforce not declared
Equity
€39.1K
Financial year 2025
Net result
€22.8K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

NAMVET is a Belgian company (Société à responsabilité limitée) whose registered office is established at 5660 Couvin. Its main activity falls under “Activités vétérinaires” (NACE 75000).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
21 November 2022
Main activity (NACE)
75000Activités vétérinaires

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Secondary activities

1 additional NACE code declared.

Your risk analysis on this company

AML Company ran NAMVET through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Couvin

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Rue de la Platinerie, Peti. 29
5660 Couvin
Map
Establishment2339.360.480
Chemin du Try Châlons 15
5660 Couvin
Map

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€39,076€22,801

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
41%
Financial year 2025

Equity / balance sheet total

Liquidity
1,83 x
Financial year 2025

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
33,1%
Financial year 2025

Debts due after one year / balance sheet total

Return on equity
58,4%
Financial year 2025

Result for the year / equity

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (1)▾
Financial yearFilingFiling typeModelSource
01/01/2025 → 31/12/202527/06/2026Initialm87-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

What the NAMVET record does not say

Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.

Is NAMVET subject to anti-money-laundering obligations in Belgium?
In principle no. The activity declared in the register for NAMVET is not among the professions expressly covered by the act of 18 September 2017. This general information is not legal advice.
Did NAMVET file its annual accounts on time?
Yes. NAMVET filed its latest annual accounts with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 27 June 2026, ahead of 31 July 2026. Article 3:10 of the Code of Companies and Associations requires filing within thirty days of approval and at the latest seven months after the financial year closes.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
2 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 27 June 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m87-fFiled accounts2026-00208732
  2. 2022
    1. 24 November 2022IncorporationView the notice22375397

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, audience-measurement cookies (hosted in the EU) to improve our services. Learn more.